About the job
At Real Chemistry, our mission is to enhance global health, this is our daily commitment. We leverage our profound scientific knowledge, human-centered creativity, and AI-powered insights to foster an environment where innovation flourishes and our team is dedicated to making an impact. As a leading global agency, we offer a comprehensive range of services in healthcare communications and marketing to esteemed clients in the pharmaceutical and biotech sectors.
Our culture, #LifeatRealChem, is deeply rooted in our people. We believe in the power of collaboration and are committed to excellence for our clients and colleagues alike. Whether you are an experienced professional or just embarking on your career, if you share our enthusiasm for healthcare and connectivity, we encourage you to explore the opportunities available.
Discover your purpose. Embrace innovation. Experience #LifeatRealChem.
Real Chemistry is actively seeking a Senior Group Director of Business Development to join our growth team in the U. S.!
This is a hybrid role, based in or near one of our U. S. locations.
We are in search of a senior-level, strategic, and enterprise-minded growth leader who can drive high-impact new business pitches, major organic growth initiatives, and capability expansion across our healthcare portfolio. Reporting to the Head of Business Strategy and Growth, you will:
Enhance the pitch process, ensuring submissions are cohesive, compelling, and aligned with the agency's strengths. Propel cross-enterprise business development efforts in sync with capabilities and global markets. Lead a matrixed team across various markets and capabilities to elevate performance. Create content, tools, and scalable processes in collaboration with corporate and capability teams.
This role is highly visible within Real Chemistry’s growth leadership team, with a clear objective to boost revenue, enhance win rates, develop scalable strategies, and ensure alignment with evolving market demands across the pharmaceutical, biotech, and life sciences sectors.
